{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:00Z","timestamp":1792510920835,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Recent studies have shown that the interaction between acute myeloid leukemia (AML) and bone marrow stromal cells (BMSCs) plays a vital role in the progression of leukemia and the development of drug resistance, while the underlying mechanisms remain inconclusive. In this study, we found that AML patient-derived BMSCs exhibit a hyperinflammatory phenotype. Histone deacetylase 3 (HDAC3) in BMSCs enhances mitochondrial reactive oxygen species (ROS) production by RAB5A-mediated blockade of mitophagy. Furthermore, we confirmed that HDAC3 regulates RAB5A expression through transcription factor YY1. Excessive ROS accelerates the senescence of BMSCs and promotes the secretion of senescence-associated secretory phenotype, creating a hyperinflammatory bone marrow niche, activating the NF-\u03baB pathway in AML cells to promote their survival and drug resistance. The inhibition of HDAC3 in BMSCs reduces the mitochondrial ROS production and thus delays BMSCs senescence. Consequently, HDAC3 inhibition in BMSCs decreases AML proliferation and synergizes with the anti-AML efficacy of venetoclax. Therefore, our study suggests that targeting HDAC3 in BMSCs may be used for the combination therapy of AML by remodeling the AML-supportive niche.<\/jats:p>","DOI":"10.1038\/s41419-025-07777-9","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:21:19Z","timestamp":1751876479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["HDAC3-YY1-RAB5A axis remodels AML-supportive niche by modulating mitochondrial homeostasis in bone marrow stromal cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6224-3484","authenticated-orcid":false,"given":"Chao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0954-5600","authenticated-orcid":false,"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-2835","authenticated-orcid":false,"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-9244","authenticated-orcid":false,"given":"Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"7777_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:502\u201326.","journal-title":"Am J Hematol"},{"key":"7777_CR2","first-page":"27","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry A, Nadorp B, Fornerod M, Nicolet D, Wu H, Walker CJ, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat cancer. 2023;4:27\u201342.","journal-title":"Nat cancer"},{"key":"7777_CR3","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1182\/bloodadvances.2024012867","volume":"8","author":"VR Minciacchi","year":"2024","unstructured":"Minciacchi VR, Karantanou C, Bravo J, Pereira RS, Zanetti C, Krack T, et al. Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression. Blood Adv. 2024;8:4983\u201396.","journal-title":"Blood Adv"},{"key":"7777_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.leu.2402608","volume":"16","author":"M Konopleva","year":"2002","unstructured":"Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia. 2002;16:1713\u201324.","journal-title":"Leukemia"},{"key":"7777_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"7777_CR6","doi-asserted-by":"crossref","unstructured":"Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Zi\u0119tek M, Matkowski R, Nowak D. Stromal Cells Present In The Melanoma Niche Affect Tumor Invasiveness And Its Resistance To Therapy. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22020529"},{"key":"7777_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/leu.2017.259","volume":"32","author":"B Kumar","year":"2018","unstructured":"Kumar B, Garcia M, Weng L, Jung X, Murakami JL, Hu X, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2018;32:575\u201387.","journal-title":"Leukemia"},{"key":"7777_CR8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nm.3364","volume":"19","author":"DS Krause","year":"2013","unstructured":"Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP, et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med. 2013;19:1513\u20137.","journal-title":"Nat Med"},{"key":"7777_CR9","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative Phosphorylation as an Emerging Target in Cancer Therapy. Clin Cancer Res : J Am Assoc Cancer Res. 2018;24:2482\u201390.","journal-title":"Clin Cancer Res : J Am Assoc Cancer Res"},{"key":"7777_CR10","doi-asserted-by":"crossref","unstructured":"Liu L, Patnana PK, Xie X, Frank D, Nimmagadda SC, Rosemann A, et al. High metabolic dependence on oxidative phosphorylation drives sensitivity to metformin treatment in MLL\/AF9 acute myeloid leukemia. Cancers. 2022;14.","DOI":"10.3390\/cancers14030486"},{"key":"7777_CR11","doi-asserted-by":"crossref","unstructured":"Chen C, Hao X, Lai X, Liu L, Zhu J, Shao H, et al. Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia. Sci Adv. 2021;7.","DOI":"10.1126\/sciadv.abd6280"},{"key":"7777_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1182\/blood-2017-03-772939","volume":"130","author":"CR Marlein","year":"2017","unstructured":"Marlein CR, Zaitseva L, Piddock RE, Robinson SD, Edwards DR, Shafat MS, et al. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts. Blood. 2017;130:1649\u201360.","journal-title":"Blood"},{"key":"7777_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","volume":"32","author":"D Forte","year":"2020","unstructured":"Forte D, Garc\u00eda-Fern\u00e1ndez M, S\u00e1nchez-Aguilera A, Stavropoulou V, Fielding C, Mart\u00edn-P\u00e9rez D, et al. Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metab. 2020;32:829\u2013843.e829.","journal-title":"Cell Metab"},{"key":"7777_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lfs.2019.02.003","volume":"221","author":"T Chen","year":"2019","unstructured":"Chen T, Zhang G, Kong L, Xu S, Wang Y, Dong M. Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy. Life Sci. 2019;221:187\u201395.","journal-title":"Life Sci"},{"key":"7777_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1158\/2643-3230.BCD-23-0043","volume":"4","author":"L Chen","year":"2023","unstructured":"Chen L, Pronk E, van Dijk C, Bian Y, Feyen J, van Tienhoven T, et al. A single-cell taxonomy predicts inflammatory niche remodeling to drive tissue failure and outcome in human AML. Blood Cancer Discov. 2023;4:394\u2013417.","journal-title":"Blood Cancer Discov"},{"key":"7777_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1158\/1541-7786.MCR-23-0382","volume":"21","author":"D Hou","year":"2023","unstructured":"Hou D, Zheng X, Cai D, You R, Liu J, Wang X, et al. Interleukin-6 facilitates acute myeloid leukemia chemoresistance via Mitofusin 1-mediated mitochondrial fusion. Mol cancer Res : MCR. 2023;21:1366\u201378.","journal-title":"Mol cancer Res : MCR"},{"key":"7777_CR17","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/bloodadvances.2017007856","volume":"1","author":"AM Stevens","year":"2017","unstructured":"Stevens AM, Miller JM, Munoz JO, Gaikwad AS, Redell MS. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance. Blood Adv. 2017;1:1387\u201397.","journal-title":"Blood Adv"},{"key":"7777_CR18","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/cas.15855","volume":"114","author":"J Lu","year":"2023","unstructured":"Lu J, Dong Q, Zhang S, Feng Y, Yang J, Zhao L. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6\/JAK2\/STAT3 signaling. Cancer Sci. 2023;114:3287\u20133300.","journal-title":"Cancer Sci"},{"key":"7777_CR19","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6:a018713.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7777_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.immuni.2024.01.002","volume":"57","author":"EM Eshleman","year":"2024","unstructured":"Eshleman EM, Rice T, Potter C, Waddell A, Hashimoto-Hill S, Woo V, et al. Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity. Immunity. 2024;57:319\u2013332.e316.","journal-title":"Immunity"},{"key":"7777_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-020-2500-6","volume":"11","author":"G Jaju Bhattad","year":"2020","unstructured":"Jaju Bhattad G, Jeyarajah MJ, McGill MG, Dumeaux V, Okae H, Arima T, et al. Histone deacetylase 1 and 2 drive differentiation and fusion of progenitor cells in human placental trophoblasts. Cell Death Dis. 2020;11:311.","journal-title":"Cell Death Dis"},{"key":"7777_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01399-w","volume":"9","author":"R He","year":"2023","unstructured":"He R, Liu B, Geng B, Li N, Geng Q. The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases. Cell Death Discov. 2023;9:131.","journal-title":"Cell Death Discov"},{"key":"7777_CR23","doi-asserted-by":"crossref","unstructured":"He R, He Z, Zhang T, Liu B, Gao M, Li N, et al. HDAC3 in action: Expanding roles in inflammation and inflammatory diseases. Cell Prolif. 2024:e13731.","DOI":"10.1111\/cpr.13731"},{"key":"7777_CR24","doi-asserted-by":"publisher","first-page":"102746","DOI":"10.1016\/j.redox.2023.102746","volume":"63","author":"N Li","year":"2023","unstructured":"Li N, Liu B, Xiong R, Li G, Wang B, Geng Q. HDAC3 deficiency protects against acute lung injury by maintaining epithelial barrier integrity through preserving mitochondrial quality control. Redox Biol. 2023;63:102746.","journal-title":"Redox Biol"},{"key":"7777_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/hep.31792","volume":"73","author":"M Song","year":"2021","unstructured":"Song M, He J, Pan QZ, Yang J, Zhao J, Zhang YJ, et al. Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression. Hepatology. 2021;73:1717\u201335.","journal-title":"Hepatology"},{"key":"7777_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/1078-0432.CCR-13-1576","volume":"20","author":"C Govindaraj","year":"2014","unstructured":"Govindaraj C, Tan P, Walker P, Wei A, Spencer A, Plebanski M. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients. Clin Cancer Res: J Am Assoc Cancer Res. 2014;20:724\u201335.","journal-title":"Clin Cancer Res: J Am Assoc Cancer Res"},{"key":"7777_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00277-023-05552-4","volume":"103","author":"JP Bewersdorf","year":"2024","unstructured":"Bewersdorf JP, Shallis RM, Sharon E, Park S, Ramaswamy R, Roe CE, et al. A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes\/neoplasms or acute myeloid leukemia refractory to hypomethylating agents. Ann Hematol. 2024;103:105\u201316.","journal-title":"Ann Hematol"},{"key":"7777_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12032-022-01911-9","volume":"40","author":"Y Wei","year":"2023","unstructured":"Wei Y, Wang L, Zhu C, Li H, Bo J, Zhang R, et al. A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation. Med Oncol. 2023;40:77.","journal-title":"Med Oncol"},{"key":"7777_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00923-4","volume":"12","author":"L Wang","year":"2020","unstructured":"Wang L, Luo J, Chen G, Fang M, Wei X, Li Y, et al. Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed\/refractory acute myeloid leukemia: a single-arm, phase 1\/2 study. Clin Epigenet. 2020;12:132.","journal-title":"Clin Epigenet"},{"key":"7777_CR30","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1182\/blood-2024-204762","volume":"144","author":"K-W Tan","year":"2024","unstructured":"Tan K-W, Pei S, Wang M, Dai L, Zhang H, Chen C-Y, et al. Comparing the Efficacy and Safety of VAC (Venetoclax, Azacitidine, Chidamide) and VA regimens as induction therapy for newly diagnosed patients with immunophenotypically mature monocytic AML. Blood. 2024;144:1507.","journal-title":"Blood"},{"key":"7777_CR31","doi-asserted-by":"publisher","first-page":"14522","DOI":"10.1021\/acsnano.1c04068","volume":"15","author":"M Jiang","year":"2021","unstructured":"Jiang M, Li X, Zhang J, Lu Y, Shi Y, Zhu C, et al. Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of macrophages under hypoxia to sensitize immunotherapy. ACS nano. 2021;15:14522\u201334.","journal-title":"ACS nano"},{"key":"7777_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","volume":"43","author":"S Binder","year":"2018","unstructured":"Binder S, Luciano M, Horejs-Hoeck J. The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators. Cytokine growth factor Rev. 2018;43:8\u201315.","journal-title":"Cytokine growth factor Rev"},{"key":"7777_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1158\/0008-5472.CAN-18-0921","volume":"79","author":"BZ Carter","year":"2019","unstructured":"Carter BZ, Mak PY, Wang X, Tao W, Ruvolo V, Mak D, et al. An ARC-regulated IL1\u03b2\/Cox-2\/PGE2\/\u03b2-Catenin\/ARC circuit controls leukemia-microenvironment interactions and confers drug resistance in AML. Cancer Res. 2019;79:1165\u201377.","journal-title":"Cancer Res"},{"key":"7777_CR34","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/MCB.21.17.5979-5991.2001","volume":"21","author":"YL Yao","year":"2001","unstructured":"Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol. 2001;21:5979\u201391.","journal-title":"Mol Cell Biol"},{"key":"7777_CR35","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","volume":"72","author":"G Gloire","year":"2006","unstructured":"Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharm. 2006;72:1493\u2013505.","journal-title":"Biochem Pharm"},{"key":"7777_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"7777_CR37","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.3389\/fimmu.2019.02787","volume":"10","author":"K Sachdeva","year":"2019","unstructured":"Sachdeva K, Do DC, Zhang Y, Hu X, Chen J, Gao P. Environmental exposures and asthma development: autophagy, mitophagy, and cellular senescence. Front Immunol. 2019;10:2787.","journal-title":"Front Immunol"},{"key":"7777_CR38","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","volume":"8","author":"HE Ramsey","year":"2018","unstructured":"Ramsey HE, Fischer MA, Lee T, Gorska AE, Arrate MP, Fuller L, et al. A Novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia. Cancer Discov. 2018;8:1566\u201381.","journal-title":"Cancer Discov"},{"key":"7777_CR39","doi-asserted-by":"crossref","unstructured":"Park E, Chen J, Moore A, Mangolini M, Santoro A, Boyd JR, et al. Stromal cell protein kinase C-\u03b2 inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance. Scie Transl Med. 2020;12.","DOI":"10.1126\/scitranslmed.aax9340"},{"key":"7777_CR40","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.122187699","volume":"99","author":"K Croizet-Berger","year":"2002","unstructured":"Croizet-Berger K, Daumerie C, Couvreur M, Courtoy PJ, van den Hove MF. The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production. Proc Natl Acad Sci USA. 2002;99:8277\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7777_CR41","first-page":"1229","volume":"10","author":"W Xu","year":"2018","unstructured":"Xu W, Shi Q, Qian X, Zhou B, Xu J, Zhu L, et al. Rab5a suppresses autophagy to promote drug resistance in cancer cells. Am J Transl Res. 2018;10:1229\u201336.","journal-title":"Am J Transl Res"},{"key":"7777_CR42","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.4161\/auto.32200","volume":"10","author":"Y Lu","year":"2014","unstructured":"Lu Y, Dong S, Hao B, Li C, Zhu K, Guo W, et al. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A. Autophagy. 2014;10:1895\u2013905.","journal-title":"Autophagy"},{"key":"7777_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41392-019-0037-x","volume":"4","author":"C Li","year":"2019","unstructured":"Li C, Huang L, Sun W, Chen Y, He M-L, Yue J, et al. Saikosaponin D suppresses enterovirus A71 infection by inhibiting autophagy. Signal Transduct Target Ther. 2019;4:4.","journal-title":"Signal Transduct Target Ther"},{"key":"7777_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol cell Biol"},{"key":"7777_CR45","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41419-021-04184-8","volume":"12","author":"Y-c Han","year":"2021","unstructured":"Han Y-c, Tang S-q, Liu Y-t, Li A-m, Zhan M, Yang M, et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 2021;12:925.","journal-title":"Cell Death Dis"},{"key":"7777_CR46","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41392-023-01520-6","volume":"8","author":"X Tang","year":"2023","unstructured":"Tang X, Zhong L, Tian X, Zou Y, Hu S, Liu J, et al. RUNX1 promotes mitophagy and alleviates pulmonary inflammation during acute lung injury. Signal Transduct Target Ther. 2023;8:288.","journal-title":"Signal Transduct Target Ther"},{"key":"7777_CR47","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D. Mitophagy in human health, ageing and disease. Nat Metab. 2023;5:2047\u201361.","journal-title":"Nat Metab"},{"key":"7777_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101963","volume":"43","author":"F Liu","year":"2021","unstructured":"Liu F, Yuan Y, Bai L, Yuan L, Li L, Liu J, et al. LRRc17 controls BMSC senescence via mitophagy and inhibits the therapeutic effect of BMSCs on ovariectomy-induced bone loss. Redox Biol. 2021;43:101963.","journal-title":"Redox Biol"},{"key":"7777_CR49","doi-asserted-by":"publisher","first-page":"9121","DOI":"10.1002\/jcp.26956","volume":"233","author":"W Wei","year":"2018","unstructured":"Wei W, Ji S. Cellular senescence: Molecular mechanisms and pathogenicity. J Cell Physiol. 2018;233:9121\u201335.","journal-title":"J Cell Physiol"},{"key":"7777_CR50","doi-asserted-by":"publisher","first-page":"797941","DOI":"10.3389\/fonc.2021.797941","volume":"11","author":"BR Wang","year":"2021","unstructured":"Wang BR, Wan CL, Liu SB, Qiu QC, Wu TM, Wang J, et al. A combined histone deacetylases targeting strategy to overcome Venetoclax Plus Azacitidine Regimen resistance in acute myeloid leukaemia: three case reports. Front Oncol. 2021;11:797941.","journal-title":"Front Oncol"},{"key":"7777_CR51","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41418-023-01139-8","volume":"30","author":"B Dai","year":"2023","unstructured":"Dai B, Wang F, Wang Y, Zhu J, Li Y, Zhang T, et al. Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RAR\u03b1. Cell Death Differ. 2023;30:1320\u201333.","journal-title":"Cell Death Differ"},{"key":"7777_CR52","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-24-0796","volume":"30","author":"H Zhou","year":"2024","unstructured":"Zhou H, Qin D, Xie C, Zhou J, Jia S, Zhou Z, et al. Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia. Clin Cancer Res: J Am Assoc Cancer Res. 2024;30:5430\u201344.","journal-title":"Clin Cancer Res: J Am Assoc Cancer Res"},{"key":"7777_CR53","first-page":"119","volume":"39","author":"R Huang","year":"2018","unstructured":"Huang R, Liu H, Chen Y, He Y, Kang Q, Tu S, et al. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL\/PI3K\/AKT\/mTOR pathway. Oncol Rep. 2018;39:119\u201328.","journal-title":"Oncol Rep"},{"key":"7777_CR54","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.actbio.2022.02.028","volume":"143","author":"C He","year":"2022","unstructured":"He C, Zhang M, Liu L, Han Y, Xu Z, Xiong Y, et al. Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF. Acta Biomater. 2022;143:406\u201317.","journal-title":"Acta Biomater"},{"key":"7777_CR55","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinforma. 2018;34:i884\u2013i890.","journal-title":"Bioinforma"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07777-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T09:03:35Z","timestamp":1751879015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07777-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7777"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07777-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient and healthy donor materials were collected after written informed consent according to the Declaration of Helsinki. AML patient material from the Zhujiang Hospital of Southern Medical University was used in this study. The study was approved by the ethical advisory board of Medical Ethics Committee of Zhujiang Hospital of Southern Medical University (No. 2022-KY-220-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"498"}}